00moonbase alphahttp://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.pngmoonbase alpha2015-09-22 14:02:402015-09-22 14:02:40MISSION Therapeutics receives funding from Innovate UK for DUB cancer programme
00moonbase alphahttp://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.pngmoonbase alpha2015-09-01 09:00:252015-09-01 09:00:25MISSION Therapeutics appoints Michael Koslowski as Chief Medical Officer
00moonbase alphahttp://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.pngmoonbase alpha2015-07-01 14:45:032015-07-01 14:45:03MISSION appoints Dr Colin Goddard to its Board of Directors
00moonbase alphahttp://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.pngmoonbase alpha2015-06-11 14:48:312015-06-11 14:48:31Prof Steve Jackson to give Sackler Lecture
00moonbase alphahttp://missiontherapeutics.com/wp-content/uploads/2017/04/mission-therapeutics-web-1.pngmoonbase alpha2015-04-24 14:52:112015-04-24 14:52:11MISSION Therapeutics presents at AACR the identification of novel inhibitors of the UCHL1 oncogene
